The efficacy and safety of favipiravir in the treatment of non-severe COVID-19: a systematic review and meta-analysis of randomized controlled trials

Muh., Akbar Bahar [Bahar, Muhammad Akbar (klinikai gyógysze...), author] Department of Clinical Pharmacy (SZTE / FP); Ikhwan, Yuda Kusuma [Kusuma, Ikhwan Yuda (klinikai gyógysze...), author] Department of Clinical Pharmacy (SZTE / FP); Mária, Matuz [Matuz, Mária (Klinikai gyógysze...), author] Department of Clinical Pharmacy (SZTE / FP); Tamás, Ferenc [Ferenci, Tamás (Biostatisztika), author]; Ria, Benkő [Benkő, Ria (Klinikai gyógysze...), author] Department of Clinical Pharmacy (SZTE / FP); Dezső, Csupor [Csupor, Dezső (Klinikai gyógysze...), author] Department of Clinical Pharmacy (SZTE / FP); Institute for Translational Medicine (UP / UPMS)

English Abstract (Journal Article) Scientific
Published: INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 2210-7703 2210-7711 44 (6) pp. 1491-1491 Paper: PDF-4.01 2022
Conference: European Society of Clinical Pharmacy (ESCP) Symposium 2022-10-19 [Prága, Czech Republic]
    Identifiers
    Fundings:
    • (TKP2021-EGA-32) Funder: NRDIO
    Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
    2024-02-22 08:32